Veradigm Inc
OTC:MDRX

Watchlist Manager
Veradigm Inc Logo
Veradigm Inc
OTC:MDRX
Watchlist
Price: 4.85 USD 5.43% Market Closed
Market Cap: 528.2m USD

Relative Value

There is not enough data to reliably calculate the relative value of MDRX.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MDRX Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
1.7
Median 5Y
1.9
Industry
2.3
Forward
0.8
vs History
vs Industry
Median 3Y
-11.6
Median 5Y
-5.9
Industry
22.5
Forward
6.4
vs History
vs Industry
Median 3Y
8.7
Median 5Y
5.6
Industry
14.4
vs History
vs Industry
Median 3Y
-10.5
Median 5Y
-6
Industry
21.4
vs History
vs Industry
Median 3Y
1
Median 5Y
1.3
Industry
2.2
vs History
vs Industry
Median 3Y
1.3
Median 5Y
1.6
Industry
2.5
Forward
0.4
vs History
vs Industry
Median 3Y
2.5
Median 5Y
3.4
Industry
5.2
vs History
vs Industry
Median 3Y
7.9
Median 5Y
9
Industry
11.9
Forward
2.4
vs History
vs Industry
Median 3Y
-39.5
Median 5Y
-29.9
Industry
16.8
Forward
3.2
vs History
vs Industry
Median 3Y
6.6
Median 5Y
3.5
Industry
14.5
vs History
vs Industry
Median 3Y
9.1
Median 5Y
4
Industry
18.6
vs History
vs Industry
Median 3Y
0.7
Median 5Y
0.8
Industry
1.9

Multiples Across Competitors

MDRX Competitors Multiples
Veradigm Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Veradigm Inc
OTC:MDRX
514.4m USD 0.9 -5.9 2.8 -14.1
US
Veeva Systems Inc
NYSE:VEEV
39.3B USD 12.8 45.7 35.2 36.8
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
22.4B AUD 101.8 194.7 134.5 134.5
JP
M3 Inc
TSE:2413
1.4T JPY 4.3 31.1 15.8 19.5
US
Doximity Inc
NYSE:DOCS
8.7B USD 14.1 34.6 30.4 31.9
US
Waystar Holding Corp
NASDAQ:WAY
5.9B USD 5.7 52.9 17.5 27.5
SE
Sectra AB
STO:SECT B
46.6B SEK 20.8 72.1 -142.4 -142.4
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
290.8B INR 10.9 59.8 37.2 43.4
CN
Winning Health Technology Group Co Ltd
SZSE:300253
20B CNY 9.2 -64.8 -128.2 -128.2
US
Inspire Medical Systems Inc
NYSE:INSP
2.9B USD 3.3 64.6 51.8 69.6
P/E Multiple
Earnings Growth PEG
US
Veradigm Inc
OTC:MDRX
Average P/E: 67.6
Negative Multiple: -5.9
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
45.7
32%
1.4
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
194.7
32%
6.1
JP
M3 Inc
TSE:2413
31.1
16%
1.9
US
Doximity Inc
NYSE:DOCS
34.6
18%
1.9
US
W
Waystar Holding Corp
NASDAQ:WAY
52.9
N/A N/A
SE
Sectra AB
STO:SECT B
72.1
17%
4.2
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
59.8
31%
1.9
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -64.8
92%
N/A
US
Inspire Medical Systems Inc
NYSE:INSP
64.6
13%
5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Veradigm Inc
OTC:MDRX
Average EV/EBITDA: 38.6
2.8
-14%
N/A
US
Veeva Systems Inc
NYSE:VEEV
35.2
39%
0.9
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
134.5
32%
4.2
JP
M3 Inc
TSE:2413
15.8
14%
1.1
US
Doximity Inc
NYSE:DOCS
30.4
23%
1.3
US
W
Waystar Holding Corp
NASDAQ:WAY
17.5
24%
0.7
SE
Sectra AB
STO:SECT B
Negative Multiple: -142.4 N/A N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
37.2
24%
1.6
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -128.2
36%
N/A
US
Inspire Medical Systems Inc
NYSE:INSP
51.8
85%
0.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Veradigm Inc
OTC:MDRX
Average EV/EBIT: 50.8
Negative Multiple: -14.1
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
36.8
39%
0.9
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
134.5
31%
4.3
JP
M3 Inc
TSE:2413
19.5
N/A N/A
US
Doximity Inc
NYSE:DOCS
31.9
25%
1.3
US
W
Waystar Holding Corp
NASDAQ:WAY
27.5
58%
0.5
SE
Sectra AB
STO:SECT B
Negative Multiple: -142.4 N/A N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
43.4
26%
1.7
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -128.2
47%
N/A
US
Inspire Medical Systems Inc
NYSE:INSP
69.6
34%
2